DrHannah Maude

I am currently a postdoctoral Research Associate in the Regulatory Genomics and Metabolic Disease group, researching the functional genomics landscape of the liver under conditions of hyperlipidemia and hyperglycemia.

I specialise in computational biology, including the analysis of whole-genome, whole-exome and targeted sequence data, as well as bulk and single-cell/nuclei RNA-seq, ATAC-seq and ChIP-seq data (see the Cebola Lab RNA-seq and ATAC-seq online tutorials).

I completed my PhD in 2019, titled 'the role of mitochondrial dysfunction in the onset of Type 2 Diabetes', carried out with Dr Toby Andrew at Imperial College. My interests cover complex and rare diseases, including the heritability of metabolic pathways and insulin resistance, mitochondrial diseases and metabolic dysfunction-associated steatotic liver disease. In particular, I study the roles of rare variants and non-coding, functional mutations in causing disease, including undiagnosed cases of mitochondrial disease registered in the 100,000 Genomics Project and other rare diseases as part of the DECODE study (collaboration with The North West Thames Regional Genetics Service).

Professional affiliations: Genetics Society Local Ambassador Imperial College (White City) and Society for Endocrinology Media Ambassador.

Science Communication: I host the DNA& podcast funded by the UK Genetics Society and regularly participate in science engagement, including at the Great Exhibition Road festival and Imperial Lates. Expert quotes provided as a SfE Media Ambassador can be seen in the Guardian, Times, Telegraph, Insider and Evening Standard.

In my spare time, I love to read popular science novels (and dream of writing my own!), paint, and play video games. For thoughts, discussions and general conversation, drop a message via my twitter!